Business Wire

CA-CEPTON-TECHNOLOGIES

1.3.2022 15:02:47 CET | Business Wire | Press release

Share
Fibre Based Integrations and Cepton Undertake Smart City Projects to Address Traffic Challenges in Cape Town

Silicon Valley-based smart lidar solution provider Cepton, Inc. (Nasdaq: CPTN) (“Cepton”) and Fibre Based Integrations , an established fiber optics systems house, are working together to develop lidar-based vehicle detection solutions in Cape Town, South Africa, to enable smart transportation infrastructure city-wide.

This joint effort combines Fibre Based Integrations’ expertise in optics system integration and Cepton’s innovative lidar technologies to help the City of Cape Town monitor lane usage and identify vehicles using incorrect lanes. Fibre Based Integrations has deployed vehicle classification systems on traffic lights at intersections and overhead devices that utilize Cepton’s Helius® Smart Lidar System with Vista®-P lidar sensors .

Many of Cape Town’s roads have designated bus lanes to ensure the efficiency of public transportation, and Fibre Based Integrations’ lidar-enabled systems will allow the city technology department to gather highly accurate, real-time lane usage data to enable analytics that help identify ways to improve traffic flow and safety for motorists and pedestrians.

By utilizing lidar’s outstanding perception capabilities, the systems can provide useful information such as vehicle size, traffic volume, frequency, lane positioning and potential obstructions. Based on this information, system operators can gain valuable insight about how a specific intersection or piece of road is being used – including unauthorized vehicle types in designated bus lanes, peak traffic time windows, real-time lane occupancy status, wait time at traffic lights and accident-prone areas.

Josh Goosen, System Engineer at Fibre Based Integrations, said: “The reason we chose to deploy lidars in our vehicle detection and classification systems is their superior accuracy. We have previously tested radars and some other types of sensors, and we found that they lack the resolution needed to accurately locate and count vehicles and provide accurate 3D information about their sizes and speeds.

We found Cepton lidars to be the best performing and most accurate compared with others we tested, and this has unlocked new possibilities for implementing our smart city solutions with the City of Cape Town.”

Lidar technology has come to play an increasingly important role in the smart cities sector. It brings a higher level of accuracy and efficiency to existing sensor technologies to help the overall system eliminate detection errors. Lidars offer a much higher spatial resolution than radars, and perform better than cameras in various weather and lighting conditions to provide high-accuracy data 24/7. Lidars also help protect people’s privacy as they do not capture biometric information , making them suitable in venues where cameras might raise privacy concerns. The addition of lidars to smart city applications helps effectively reduce false negatives and false positives, while making systems more data efficient.

Cepton’s lidars use a patented imaging technology called Micro Motion Technology (MMT®) to help system integrators maximize the benefit of the lidar technology. The rotation-free, mirrorless and frictionless MMT design makes Cepton lidars reliable, rugged and compact, which in turn offers ease of integration and affordability for scalable applications.

In the solutions deployed by Fibre Based Integrations, Cepton’s Vista-P lidar sensors are interconnected through the Helius perception software, creating a network of smart lidar sensors to offer real-time detection, tracking and classification of vehicles and pedestrians. This enables extendable smart transportation infrastructure that collects and analyzes traffic data from different locations, while helping optimize its overall bandwidth allocation, as lidars output only a fragment of the data volume output from video camera-based alternatives.

Fibre Based Integrations and City of Cape Town are also exploring using Cepton’s lidars to augment the city’s analog and video systems with an additional layer of functionality and performance. The aim is to blend human and vehicle classification, enabled by lidar, with an AI platform to understand how both interact with the city environment. This will help collect useful information for traffic management and urban planning through machine learning, while minimizing disruption to people’s daily lives.

Klaus Wagner, Director of Product Management and Marketing at Cepton, added: “If our cities are to become smarter, then plug and play solutions like the ones we have created with Fibre Based Integrations must play a vital role in helping them do so.

Lidar has the ability to make people’s everyday lives easier even without them being fully aware of it, and that is what makes smart transport systems so intelligent. We look forward to continuing our work with Fibre Based Integrations in our effort to make Cape Town and other cities in South Africa safer. We also believe that by enabling a higher level of traffic efficiency, we can help cities build a greener environment.”

About Cepton, Inc.

Cepton is a Silicon Valley innovator of lidar-based solutions for automotive (ADAS/AV), smart cities , smart spaces and smart industrial applications. With its patented Micro Motion Technology (MMT®), Cepton aims to take lidar mainstream and achieve its vision of safe and autonomous transportation for everyone.

Cepton has been awarded the largest known ADAS lidar series production award in the industry to date, based on the number of vehicle models awarded, to support General Motors’ Ultra Cruise program. Cepton is also engaged with all other Top 10 global OEMs.

Founded in 2016 and led by industry veterans with decades of collective experience across a wide range of advanced lidar and imaging technologies, Cepton is focused on the mass market commercialization of high performance, high quality lidar solutions. Cepton is headquartered in San Jose, CA and has a center of excellence facility in Troy, MI to provide local support to the OEM and Tier 1-studded Metro Detroit area. Cepton also has a presence in Germany, Canada, Japan, India and China to serve a fast-growing global customer base. For more information, visit www.cepton.com and follow Cepton on Twitter and LinkedIn .

About Fibre Based Integrations

Fibre Based Integrations is an established fibre optic systems house serving major project houses and end users in the Telecommunications, CCTV, Process and Datacomms industry.

Our success in attracting business from our customers is as a result of our commitment to supply a total turnkey solution and to maintain a general quality standard that permeates all aspects of the project, from documentation to all the components and the optical line terminating equipment used.

As a result of years of experience gained in the field of fibre installation and integration, our highly skilled installation staff is the foundation on which the company is built. To enable Fibre Based Integrations to work to the most exacting standards, the installation teams are backed by the latest state of the art fusion splicing machines, OTDR testing equipment and installation equipment. All commissioning activities are conducted to fully documented procedures, which form an intrinsic part of the final hand-over.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study23.10.2026 13:30:00 CEST | Press release

Data from the Registrational Phase 3 G-HOPE-001 Study of Arcotatug Tavatecan, a Novel, Potential Best-in-Class Claudin (CLDN)18.2 ADC, were Highlighted in a Late-Breaking Presentation at ESMO 2026Arcotatug Tavatecan Met Dual Primary Endpoints of Overall Survival and Progression-Free Survival, Showing Significant Improvements vs. Treatment of Physician’s Choice in Patients with Previously Treated CLDN18.2-Positive Advanced Gastric CancerFindings to Support Planned Regulatory Filing in Japan and Continued Global Development of Arcotatug Tavatecan in CLDN18.2-Positive Cancers Takeda(TSE:4502/NYSE:TAK)announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: IBI343) in patients with Claudin (CLDN)18.2-positive, previously treated, advanced gastric or gastroesophageal junction adenocarcinoma (G/GEJA). Results from two prespecified interim analyses, which were shared in a late-breaking oral presentation at the 2026 European

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye